Brief: Inovio launches Zika vaccine trial

Gene One Life Science

29/08/2016 12:00

Aug 29 (Reuters) - Inovio Pharmaceuticals Inc  INO.O  
    * Inovio launches Zika vaccine trial in midst of Puerto Rico 
epidemic to explore early signals of vaccine efficacy 
    * Expects to report results before end of this year 
    * Is developing its Zika vaccine, GLS-5700, with Geneone 
Life Science, Inc.  And academic collaborators from US and 
Canada 
 
Source text for Eikon:  ID:nGNXNABAUa  
Further company coverage:  INO.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))